Location History:
- Lund, SE (1996)
- 67 Lund, SE (1994 - 1998)
- Knivsta, SE (1993 - 1999)
Company Filing History:
2 out of 207 
1 out of 8 
2 out of 832,912 Years Active: 1993-1999
Title: Torkel Mikael Wadstrom: Innovator in Vaccine Development
Introduction
Torkel Mikael Wadstrom is a prominent inventor based in Lund, Sweden. He has made significant contributions to the field of vaccine development, particularly in relation to Staphylococcus aureus. With a total of 5 patents, his work has the potential to impact public health and veterinary medicine.
Latest Patents
Wadstrom's latest patents include a vaccine composition that comprises an effective amount of an isolated protein derived from Staphylococcus aureus. This protein has the ability to bind fibronectin and has a molecular weight of 165,000 daltons. Additionally, it may contain a protein with a molecular weight of 87,000 daltons. The invention aims to elicit antibody production sufficient to provide protection against Staphylococcus aureus in mammals, particularly ruminants. Another notable patent involves a recombinant hybrid-DNA molecule that encodes a protein with fibronectin binding properties.
Career Highlights
Throughout his career, Torkel Mikael Wadstrom has worked with various organizations, including Alfa Laval Corporation. His innovative research has led to advancements in vaccine technology, showcasing his dedication to improving health outcomes.
Collaborations
Wadstrom has collaborated with notable individuals in his field, including Magnus Hook and Martin K Lindberg. These partnerships have contributed to the success of his research and patent developments.
Conclusion
Torkel Mikael Wadstrom's contributions to vaccine development highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and public health.